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Abstract
BLOOD GLUCOSE MONITORING AND METABOLIC CONTROL IN YOUTH
WITH TYPE 1 DIABETES: RELATION TO DISEASE CARE
By: Adrienne P. Borschuk, B.A.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2012.
Director: Clarissa Holmes, Ph. D.
Professor
Departments of Psychology, Pediatrics and Psychiatry

Better disease care behaviors in youth with type 1 diabetes (T1D) are strongly
related to better metabolic control (HbA1c). However, HbA1c results are only available,
on average, every three months, and may not accurately capture intricacies of blood
glucose fluctuations. Youth then must rely on blood glucose levels obtained throughout
the day to determine which disease care behaviors to perform to maintain optimal
metabolic control. Youth may have difficulty performing these disease care behaviors
properly or consistently, which makes parental monitoring a crucial aspect of the diabetes
regimen. Additionally, youth who experience frequent or severe hypoglycemia may
develop a fear of hypoglycemia, which may impact their disease care behaviors and
blood glucose levels directly.
Average blood glucose levels strongly related to HbA1c which verifies HbA1c as
a good indicator of average blood glucose levels. The Average Daily Risk Range

vii
(ADRR) index had a stronger relation to HbA1c than Mean Amplitude of Glycemic
Excursions (MAGE) index; however, the percentage of blood glucose levels below,
within, and above range may be the best indicator of glycemic variability, as it is more
easily calculated and understood. More parental monitoring related to more diabetes
prevention behaviors but not intervention behaviors or less glycemic variability.

Blood Glucose Monitoring and Metabolic Control in Youth with Type 1 Diabetes:
Relation to Disease Care
Type 1 diabetes (T1D) is a chronic illness that affects 0.22% of youth in the
United States and involves a variety of disease care behaviors. Adherence to the diabetes
care regimen, critical for avoidance of health complications over time, is measured by
glycosylated hemoglobin (HbA1c) levels; however, these are only available, on average,
every three to four months to guide disease care decisions. Blood glucose monitoring is
an alternate way to measure adherence to disease care, and in contrast to the average of
HbA1c over a longer period, youth can use blood glucose monitors several times a day to
measure and adjust acute fluctuations. These glycemic fluctuations, if chronic, may lead
to long-term health complications. Psychosocial factors, such as youth and parent fear of
hypoglycemia and parental monitoring, can affect youth disease care behaviors, blood
glucose levels, and ultimately metabolic control.
The proposed study will examine blood glucose data and frequency of blood
glucose monitoring as it relates to HbA1c. Blood glucose levels have been significantly
related to HbA1c levels in a number of studies; however, to this date, blood glucose data
has not been delineated into categories of below, within, and above the ADA
recommended levels. Separation of blood glucose data into categories may reveal a
clearer picture of the association. The contribution by youth and parent fear of
hypoglycemia to the relation between HbA1c and blood glucose levels below, within, and
above range will be examined. Glycemic variability has also been shown to have a
strong relation to HbA1c, but measures of glycemic variability have not been assessed in
depth to this date. Two measures of glycemic variability, Average Daily Risk Range
(ADRR) and Mean Amplitude of Glycemic Excursions (MAGE), will be compared to
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determine which is more closely correlated with HbA1c. Finally, the impact of parental
monitoring on prevention and intervention behaviors in response to blood glucose levels
will be examined.
T1D will be explained first, followed by a description of metabolic control and
two methods of assessing metabolic control. Then, the youth diabetes regimen will be
introduced and disease care behaviors explained. Lastly, youth and parent fear of
hypoglycemia and parental monitoring will be examined to determine the relation to
metabolic control. The relations between psychosocial factors, disease care behaviors,
and indicators of metabolic control will be examined in the context of bioecological
theory.
Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease with short- and long-term health
complications (Singer, Coley, Samet, & Nathan, 1989). T1D accounts for approximately
10% of all cases of diabetes, with 215,000 youth diagnosed in 2011 (American Diabetes
Association [ADA], 2011). T1D is characterized by immune system destruction of the
insulin-producing cells of the pancreas. Insulin allows glucose obtained from nutritional
intake to permeate the cellular membrane for energy and stimulates liver and muscle cells
to store glucose as glycogen (Johnson, 1988). When insulin is destroyed, the body is
unable to regulate blood glucose levels, and excess glucose accumulates in the blood
(Johnson, 1988). When glucose from nutritional intake enters the bloodstream, it merges
with red blood cells in a process called glycosylation (Cnop et al., 2005). With excess
glucose in the blood, more hemoglobin is glycosylated, which results in higher HbA1c
levels (Fishbein & Palumbo, 1995).
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If the multifaceted diabetes regimen is not followed, both long term and acute
complications can result. Ideally, all individuals in a youth’s environment must
understand and participate in the diabetes treatment of a youth to avoid complications.
Acute complications may include hyperglycemia or hypoglycemia, which result in
symptoms of dizziness, confusion, weakness, hunger, thirst, and irritability (Johnson,
1988). Long term complications include organ damage due to retinopathy, neuropathy,
and nephropathy (ADA, 2011; Expert Committee on the Diagnosis and Classification of
Diabetes Mellitus, 2002).
Diabetes in the Context of Bioecological Theory
Diabetes is a chronic illness influenced by biological, psychological, and social
factors within the family. The bioecological theory views a youth’s context as a set of
nested structures, or structures within structures, which highlight the transactional nature
of human development (Bronfenbrenner, 1977). A youth primarily exists in his or her
home, which is the foundation for development; secondary settings, such as school,
surround this primary environment and influence a youth’s growth. Furthermore, a
youth’s interpersonal interactions have reciprocal influence, and youth affect others’
development as well. A youth is the center of his or her individual ecosystem, and the
proximal surrounding environment is the microsystem. A microsystem is a set of
interactions between a youth and his or her immediate environment. This setting is a
place where a youth engages in activities in distinct roles for periods of time. An example
of a youth’s microsystem is home or school, two places where a youth’s functions
conspicuously differ. Parental monitoring primarily exists at this level of a youth’s
ecosystem; straightforward interactions between a youth and parent most commonly take
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place at home, which is also where most disease care behaviors are anchored. Because
most of a youth’s diabetes supplies are at home, and a youth’s day begins and ends in the
home, it is important for a parent to be involved in the daily routine to provide a stable
framework for the diabetes regimen.
The second layer of a youth’s ecology is the mesosystem, which is a system of
microsystems. An example of a mesosystem is the interrelation between a youth’s school
and home. This is a vital transition for a youth with T1D; if their diabetes regimen is
inconsistent between these two systems, metabolic control may suffer due to resultant
glycemic excursions (Silverstein et al., 2005). External to the microsystem is the
exosystem, which is the connection between two or more settings, one of which does not
ordinarily encompass a youth. An example is a youth’s home and a parent’s workplace.
A parent preoccupied with thoughts of work may forget to monitor their youth’s blood
glucose as frequently as recommended. These examples show the influence exerted by
parental monitoring at these levels of a youth’s environment, and potential availability to
monitor or make modifications to the disease care regimen.
The outermost ring of Bronfenbrenner’s ecological model is the macrosystem,
which prototypically exists as society and sets patterns for activities and structures to
occur at the concrete level. This includes culture and social beliefs. A youth who
believes he or she should be embarrassed about having T1D is likely to modify his or her
behavior accordingly, which may result in a reduction in blood glucose monitoring, or
refusal to administer insulin in response to hyperglycemia. Any decline in self-care
behaviors resulting from transactions at any systems level may affect metabolic control.
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Bronfenbrenner postulated that the four levels of a developing youth’s ecosystem
change over time, and emphasizes interactions between a youth and his or her
environment, as well as interactions between levels (1977). The transactional framework
should be in the forefront when considering youth development. In the structure of
psychosocial development, a youth who is predisposed to anxiety is influenced by
interactions he or she has within the microsystem, exchanges between mesosystems, and
exosystems. The macrosystem sets a larger cultural context which influences all levels
and interactions as well, resulting in the emergence or absence of disease-specific
anxiety, fear of hypoglycemia, in a youth. Within these contexts, a youth’s fear of
hypoglycemia may be influenced or catalyzed by a parents’ anxiety, and potentially
causes a reinforcement loop of anxious interactions.
Factors to be examined in this study exist at the micro-, macro-, and exosystem
level. A youth’s fear of hypoglycemia relates to behavior at home and interactions with
family members. Anxiety may manifest itself in avoidance behaviors such as avoidance
of insulin injection. Interpersonal interactions also may become strained due to a youth’s
anxious emotional state, or a parent’s reaction to a youth’s reduced self-care behaviors.
Hypoglycemia, hyperglycemia, and glycemic excursions effect physical and emotional
reactions to the micro- and macro-systems. Finally, parental monitoring affects the
micro- and macro-systems, and is influenced by the exosystem. Consistency in the
diabetes regimen is crucial, and parental monitoring is necessary for this stability across
microsystems. The exosystem sets a larger stage for attitudes about diabetes care. These
bonds are bidirectional transactions, which embodies youth development. A chronic
illness like T1D adds a layer of complexity to the theoretical model.
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Hyperglycemia
Hyperglycemia occurs with too little insulin in the body to allow cellular uptake
of blood glucose, typically identified when blood glucose levels exceed 200 milligrams
of glucose per deciliter of blood (mg/dL). Symptoms of hyperglycemia include frequent
urination, increased thirst and appetite, blurred vision, fatigue, and weight loss
(Silverstein et al., 2005). If not treated properly, hyperglycemia may lead to diabetic
ketoacidosis (DKA), a state in which the body metabolizes fat for energy, and creates
ketones that accumulate in the bloodstream and are expelled through the urine (Scibilia,
Finegold, Dorman, Becker, & Drash, 1986). Symptoms of DKA include nausea,
vomiting, and dry mouth. Treatment for DKA consists of fluid replacement, electrolyte
replacement, insulin therapy, or exercise (Scibilia et al., 1986). Left alone to manage
mild or moderate hyperglycemia, many youth do nothing (Johnson, Perwien, &
Silverstein, 2000; Wysocki, Greco, & Buckloh, 2003). Determination of the relation
between intervention and prevention behaviors taken by youth and parental monitoring
will help explain how to improve disease care behaviors among youth with T1D.
Hypoglycemia
Hypoglycemia occurs when blood glucose drops below 70 mg/dL, indicating
insufficient fuel for bodily needs. Symptoms include shakiness, dizziness, headache, and
difficulty paying attention. Cognitively, patients also may experience declines in
planning and decision making, attention to detail, and reaction time (Ryan et al., 1990).
If untreated with glucose, hypoglycemia can lead to seizures, coma, and ultimately death.
The American Diabetes Association (2011) recommends hypoglycemia be treated with
15 to 20 grams of carbohydrates or sugars, wait 15 minutes, retest and repeat as needed
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until euglycemia is achieved. Youth are more likely to take corrective action with
hypoglycemia, but often overtreat such that it is followed by an episode of hyperglycemia
(Hardin, 2004; Susman-Stillman, Hyson, Anderson, & Collins, 1997; Wysocki et al.,
2003). Younger age is a consistently reported risk factor for hypoglycemic episodes,
with rates in preschool-age youth three-fold higher than those in adolescents, suggesting
a need for more parent or adult monitoring (Bognetti et al., 1997; Levine, Anderson,
Butler, Brackett, & Laffel, 2001). Other reported risk factors include lower HbA1c levels
(DCCT, 1993; Mortensen & Hougaard, 1997), male gender (Davis et al., 1998), and
longer duration of diabetes (Bott, Bott, Berger, & Mühlhauser, 1997; DCCT, 1993).
While lower blood glucose levels correlate with better metabolic control (p < 0.001) and
fewer long-term diabetes-related complications such as retinopathy (p =0.087) and
nephropathy (p =0.042; DCCT, 1993), a greater likelihood of severe hypoglycemia is
present. Beyond acute hypoglycemia, more chronic cognitive sequelae such as
diminished memory, reading impairment, and reduced visuo-spacial ability may be found
in youth with diabetes onset before age seven, or disease duration of more than five years
(Puczynski, Puczynski, & Ryan, 1992).
Long-term T1D Complications
Retinopathy is an ocular manifestation of systemic disease (ADA, 2002). When
blood glucose levels are consistently elevated, blood vessels are unable to contain the
excess volume caused by higher sugar concentration and burst, ultimately leading to
blindness if uncorrected (Mayo Foundation for Medical Education and Research
[MFMER], 2010). Neuropathy occurs when nerves are damaged by continuous
hyperglycemia. Decreased blood flow causes pain, loss of feeling in extremities, muscle
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cramps, numbness, and weakness (MFMER, 2010). Diabetic nephropathy is a
progressive kidney disease caused by angiopathy of capillaries in the kidney glomeruli
(Berkman & Rifkin, 1973). Symptoms result from gradual kidney failure, and patients
usually resort to kidney dialysis treatment if the disease worsens (Berkman & Rifkin,
1973).
The landmark Diabetes Control and Complications Trial (DCCT, 1993) found
good metabolic control predicts a reduction in the rate and progression of future disease
complications. Complications are minimized if youth perform recommended disease
care behaviors and maintain a lower HbA1c level, indicative of less glycosylation and
better metabolic control. Disease care behaviors must be consistent and accurate, which
requires support from all systems within a youth’s environment.
Metabolic Control
Glycosylated hemoglobin (HbA1c) measures average plasma glucose
concentration over the previous two to three months, and is a composite index of
metabolic control (Clarke, Snyder, & Nowacek, 1985). Research indicates that the major
proportion of HbA1c is related to a shorter period of the previous two to four weeks, and
may be more heavily influenced by afternoon and evening blood glucose levels (Rohlfing
et al., 2002). Blood glucose levels in the preceding 30 days contribute approximately
50% to the final result, and blood glucose levels from 90–120 days earlier contribute only
10% (Goldstein, Little, Wiedmeyer, England, & Rohlfing, 1993; Tahara, 1993). Due to
uneven temporal contributions to HbA1c, it has been suggested that measures of
glycemic variability be included as indicators of overall metabolic control (Brownlee &
Hirsch, 2006; DCCT, 1995; Hirsch & Brownlee, 2005; Kovatchev, 2006). HbA1c is the
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most commonly used index of metabolic control to benchmark disease complications.
Non-diabetic HbA1c levels range from 4% to 5.9%. Typically, HbA1c levels in youth
with T1D range from 6% to above 14% (Silverstein et al., 2005). Lower scores are better
and indicate less glucose in the bloodstream is ‘glycosylated’, or irreversibly bound to
hemoglobin molecules. HbA1c is higher in diabetic youth due to the lack of insulin in
the blood and resulting excess sugar in the bloodstream. Although HbA1c is an accurate
overall measure of metabolic control, it does not provide information about day-to-day
blood glucose fluctuations, or immediate, real-time feedback which patients can
instantaneously use to make medical or lifestyle choices (Dailey, 2007).
Once blood glucose levels are known, steps can be taken to correct high or low
blood sugars to avoid acute complications of thirst, nausea or dizziness, and shakiness,
respectively. Lowered HbA1c occurs as a result of better diabetes regimen adherence;
HbA1c is strongly correlated with average blood glucose levels in adults, ranging from (r
= 0.62) to (r = 0.66), respectively (Derr, Garrett, Stacy, & Saudek, 2003; Service &
O’Brien, 2007). A very strong correlation exists between average blood glucose levels
and HbA1c in adolescents, (r = 0.71, p < .0001; Hempe, Gomez, McCarter, & Chalew,
2002). Poorer metabolic control in adults is correlated with higher levels of HbA1c and
wider fluctuations in blood glucose levels, confirming HbA1c as a good measure of
average glycemia (Derr et al., 2003). Although much research has examined the relation
between average blood glucose levels and HbA1c, little of this research has been
conducted in youth populations with T1D. Research with pediatric populations is
difficult to conduct, as this age group is complex. Youth’s roles within microsystems are
fluid during transitional periods and affect the interactional layers of a youth’s ecosystem
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(Strawhacker, 2001). Accounting for levels of parental monitoring is a key difference
between adult and pediatric studies. Parental monitoring in blood glucose levels is
increasingly studied as a key factor related to better disease management in pediatric
diabetes research. Recognition and treatment of out-of-range blood glucose levels is a
responsibility managed by many parents of youth with T1D, and decreased blood glucose
monitoring in adolescence is frequently related to poorer metabolic control (Anderson et
al., 2002; Ingerski, Anderson, Dolan, & Hood, 2010; Sander, Odell, & Hood, 2010).
Glycemic Variability
A principal factor affecting metabolic control is idiosyncratic variations in blood
glucose events (Wearden, Hynd, Smith, Davies, & Tarrier, 2006). Adults with T1D who
attribute blood glucose fluctuations to individual unpredictability report poorer metabolic
control (Wearden et al., 2006). Researchers have begun to focus on phenotypic glycation
responses, or individual differences in the relation between HbA1c levels and average
blood glucose levels in individuals with similar preceding blood glucose levels.
Phenotypic glycation responses in adolescents were examined as a possible explanation
for the relation between average blood glucose levels and metabolic control in
adolescents (Hempe et al., 2002). Investigators found a strong linear correlation between
average blood glucose levels and HbA1c in adolescents, but results suggest sample
variability in HbA1c levels is attributable to idiosyncratic blood glucose responses among
individuals. Results led authors to conclude that average blood glucose levels and
HbA1c were not interchangeable measures of metabolic control, and youth with T1D
would benefit from more than one overall indicator of metabolic control. Additional
research should be conducted to explore the validity of these findings, and discern
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whether this connection may be explained by typical hormonal fluctuations present
during adolescence (Amiel et al., 1986) or the difficulty of parent/youth teamwork to
manage disease care (Anderson, Ho, Brackett, Finkelstein, & Laffel, 1997; Anderson et
al., 2002).
Extreme glycemic variability in adults with T1D results in an activation of
oxidative stress, which may lead to complications due to poorer metabolic control
(Brownlee, 2001). Oxidative stress is an imbalance between production and
manifestation of reactive oxygen species and a biological system's ability to readily
detoxify the reactive intermediates or to repair the resulting damage. This process can
damage all components of the cell. Oxidative stress is involved in many diseases, such as
atherosclerosis, heart failure, and heart attacks (Gems & Partridge, 2008). A wider
fluctuation in blood glucose levels is strongly correlated with poorer metabolic control (r
= 0.65, p < .001; Derr, Garrett, Stacy, & Saudek, 2003). Evidence suggests disease
complications may occur due to glycemic excursions, which may not consistently be
reflected in HbA1c levels. Consequently, measures of blood glucose fluctuations are
recommended for inclusion with HbA1c as a more comprehensive marker of metabolic
control (Brownlee & Hirsch, 2006; DCCT, 1995; Hirsch & Brownlee, 2005; Kovatchev,
2006).
Many methods exist by which blood glucose fluctuations are analyzed. The
methods investigated in this study include Average Daily Risk Range (ADRR) and Mean
Amplitude of Glycemic Excursions (MAGE).
Average Daily Risk Range (ADRR). The ADRR formula requires at least 14
days out of 30 days where three blood glucose readings were taken per day (Kovatchev et
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al., 2006). Blood glucose values are normalized using a logarithmic data transformation
that matches the clinical and numerical center of the blood glucose scale, thus making the
transformed data symmetric; without this data transformation, many parametric statistical
assumptions are violated unknowingly. After this transformation, investigators found the
low blood glucose index predicted the occurrence of severe hypoglycemia (r = 0.68, p <
0.001), the high blood glucose index predicted the occurrence or hyperglycemia (r =
0.60, p < 0.001), and the high blood glucose index correlated with the subjects'
glycosylated hemoglobin (r = 0.63, p < 0.001), while raw blood glucose data did none of
those (Kovatchev, Cox, Gonder-Frederick, & Clarke, 1997). After the data are
transformed, blood glucose readings are converted into risk values, using all of the
readings below the mean and all of the readings above the mean as overall indicators of
risk for hypo- and hyperglycemia (Kovatchev et al., 2006). The ADRR values may be
categorized into three groups: low risk, moderate risk, and high risk. The optimal data
period was one month, with three to five blood glucose checks per day.
ADRR has several attributes which set it apart from alternative measures of
glycemic variability. Besides creating a more balanced picture of daily fluctuations, the
ADRR method of centering blood glucose levels also ensures greater validity and
sensitivity of the data, rendering results clinically meaningful. With more valid blood
glucose data, interpretations made may be more consequential. ADRR also significantly
predicts the risk of severe hypo- and hyperglycemia, which other variability measures,
and HbA1c, are unable to do. Valid prediction of glycemic events could aid in
identification of youth at risk for severe glycemic events, and subsequently modify
treatment plans to improve metabolic control and reduce glycemic fluctuations. Re-
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analysis of data suggests the ADRR captures group and/or treatment effects undetected
by HbA1c (Cox et al., 1995). Finally, because the transformation included in the ADRR
calculation centers blood glucose data at zero, it may be applied to any data sample
without parametric re-estimation or risk of violating statistical assumptions (Kovatchev et
al., 1997). As stated above, in contrast to previously used measures of glycemic
variability, ADRR applies equal weight to hypo- and hyperglycemia, rendering it a
balanced measure of overall glycemic variability than those that previously exist. A table
is included below. Although the three participants have the same HbA1c level, daily
blood glucose levels and fluctuations are very different.

The graphical representation (Kovatchev et al., 2006) above makes it clear that in
order to properly assess metabolic control among youth with T1D, a measure of glycemic
13

variability should be included along with the traditional HbA1c level during the
endocrinology appointment.
Mean Amplitude of Glycemic Excursions (MAGE). MAGE is the other most
prevalent method used to measure average daily fluctuations in blood glucose levels. To
calculate MAGE, the difference from the previous blood glucose value is calculated for
each individual blood glucose value. Each difference score is compared against the
average of all blood glucose values in that day and only differences exceeding one
standard deviation from the average are included. The arithmetic mean of the remaining
differences is calculated, resulting in the glycemic variability value. Participants with
T1D were found to have larger, or worse, MAGE values than participants without T1D,
and “unstable diabetics” had larger MAGE values than “stable diabetics” (Service et al.,
1970). Diabetic participants were categorized as “highly unstable,” “moderately
unstable,” and “stable” based on their relative difficulty in maintenance of euglycemia
throughout the study. MAGE is strongly correlated with total variability (r = 0.89) and
within day variability (r = 0.87), but less strongly correlated with various measures of
between day variability, ranging from r = 0.46 to r = 0.76 (Rodbard, 2009).
MAGE has been used in several clinical studies that measured cognitive
performance, oral insulin efficacy and improvement in metabolic control (Marfella et al.,
2010; Rizzo et al., 2010; Rodbard, Jovanovic, & Garg, 2009). In older adults with type 2
diabetes (T2D), a larger MAGE was associated with poorer cognitive functioning,
independent of HbA1c levels (Rizzo et al., 2010). MAGE was found to decrease when
more efficacious oral insulin was added to the insulin regimen of adults with T2D
(Marfella et al., 2010). Continuous glucose monitoring was found to improve MAGE,
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HbA1c, and average blood glucose levels in adults with T1D (Rodbard et al., 2009).
MAGE is the predominant calculation used in blood glucose data analysis for T1D and
T2D (Monnier & Colette, 2008).
The ADRR and MAGE indices of glycemic excursion were compared following
development of the ADRR calculation, albeit only with adult populations. The ADRR
was found to better predict hypoglycemia than MAGE (Kovatchev, et al., 2006). Authors
maintain ADRR weighs hypo- and hyperglycemia equally, while other glycemic
variability measures bias towards hyperglycemia. ADRR was shown to be more
sensitive than MAGE to the degree of glucose fluctuations, although MAGE was found
to be more sensitive in detecting the percentage of glucose values “within range”
(Rodbard et al., 2009). Available evidence suggests a better understanding of the relation
between glycemic variability measures and HbA1c will aid in monitoring overall
metabolic control of youth with T1D, as well as tailoring care to prevent complications
due to glycemic excursions.
Disease Care Behaviors
Daily recommendations for T1D include administration of insulin, adjustment of
insulin levels in response to blood glucose levels, maintenance of a healthy diet, exercise,
and several blood glucose level checks throughout the day (Silverstein, et al., 2005).
Diabetes regimens vary based on youth differences, but adherence is generally defined as
the degree to which a youth’s disease care behaviors correspond to medical or health
advice (Haynes, 1979).
An overall adherence rate of 50% is estimated for disease care behaviors in most
pediatric chronic illnesses (Litt & Cuskey, 1980), but rates may vary depending on the
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complexity of the disease care regimen, age of the patient, or whether the treatment
regimen is short- or long-term (Sackett & Snow, 1979; Epstein & Cluss, 1982).
Adolescents describe performance of disease care behaviors as increasingly difficult over
time (Kovacs et al., 1989). In a meta-analysis of 21 studies, poorer disease care
behaviors related to higher HbA1c levels (Hood, Peterson, Rohan, & Drotar, 2009).
Insulin regimen, nutrition, and exercise are all important factors which influence
metabolic control; however, the frequency of blood glucose monitoring is consistently
shown to have a strong correlation with metabolic control (Anderson, Ho, Brackett,
Finkelstein, & Laffel, 1997; Jones et al., 2003).
Insulin Regimen
The most common types of insulin regimen are Basal/Bolus regimens,
Continuous Subcutaneous Insulin Infusion (CSII) via an insulin pump, and Multiple
Daily Injections (MDI) (Silverstein et al., 2005). The MDI regimen consists of two or
three injections of short- and intermediate-acting insulin, sometimes combining both
types into one injection. Insulin doses are adjusted based on blood glucose readings,
exercise, and nutritional intake. The MDI regimen requires a strict injection schedule to
be effective (Silverstein et al., 2005).
Basal/Bolus regimens use short-acting boluses, or bursts, of insulin to compensate
for meals and snacks, and long-lasting basal insulin rates to maintain consistent levels of
insulin in the body (Silverstein et al., 2005). Basal/Bolus regimens are more flexible than
multiple daily injections due to the basal rate of long-lasting insulin present. Longlasting insulin is typically administered in the morning to compensate for food consumed
while the youth is awake, with supplemental short-acting insulin injections as needed.
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Insulin pump therapy, or CSII, requires a catheter to be inserted under the skin.
The pump continuously administers a steady flow of microunits of insulin through the
catheter tube (Boland, Grey, Oesterle, Fredrickson, & Tamborlane, 1999). The basal rate
can be changed at any time, and boluses of insulin can be delivered as needed without
injections via an indwelling catheter, provided sufficient insulin levels are available in the
pump reservoir. Insulin pump therapy reduces the risk of long-term complications from
diabetes due to the continuous steady flow of insulin which better mimics natural
physiology and results in better metabolic control (Boland et al., 1999).
The stepwise transition from MDI to Basal/Bolus to CSII regimens includes
qualitative changes in disease care behaviors. While blood glucose monitoring is crucial
for every insulin regimen, each increase in regimen intensity necessitates more frequent
blood glucose tests, which results in better metabolic control if the new regimen is
implemented properly (Chisholm et al, 2007). Youth and parents should be thoroughly
educated before a change in regimen to ensure a seamless transition. Each regimen
utilizes a unique combination of insulin, based on intensity and complexity.
Frequency of Blood Glucose Monitoring
The ADA recommends youth check blood glucose levels four or more times a day
(ADA, 2011; Silverstein et al., 2005). If youth with T1D neglect aspects of their
regimen, blood glucose levels will vary beyond the prescribed range of greater than 70
mg/dl and less than 200 mg/dl, and ultimately result in poorer HbA1c levels if prolonged
(Hood, Rohan, Peterson, & Drotar, 2010). Blood glucose monitoring is a tool for youth
to access and keep blood glucose levels within range, and frequency of blood glucose
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monitoring is moderately correlated with metabolic control (r = 0.44, p <.02; Anderson,
et al., 1997).
Conventional Blood Glucose Monitoring
Blood glucose meters allow youth to monitor if they are in an optimal blood
glucose range, and modify disease care behaviors to stay within this range (Silverstein, et
al., 2005). Ideally, youth use blood glucose readings to adjust the amount of insulin
taken, to coordinate the amount of food consumed, and to determine levels of physical
activity. Individual regimen differences exist; youth on MDI typically only adjust insulin
for extreme hyperglycemia, while youth using Basal/Bolus and insulin pump regimens
are able to make acute insulin adjustments based on unplanned snacks or exercise.
Blood glucose meters measure the concentration of glucose in the blood. After
pricking a finger with a lancet, youth place a drop of blood on a test strip inserted into a
meter, which calculates the amount of glucose in the sample. Blood glucose monitors are
able to calculate blood glucose levels in a matter of seconds. This is critical, particularly
for hypoglycemia, which can worsen rapidly. When used correctly, glucose meters
demonstrate a high degree of clinical accuracy on par with laboratory instruments used to
measure blood glucose (Renard, 2005; Weinzimer et al., 2005).
Current meters also include a clock and memory capacity which allows youth to
review results and detect patterns in their blood glucose numbers. In a study of 47 youth
with T1D, 74% referenced historical readings from a blood glucose meter to modify their
diabetes regimen at least once during the four-week long study (Wysocki, Hough, Ward,
Allen, & Murgai, 1992). Data did not correlate significantly with HbA1c, but modestly
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related to more diabetes knowledge and better treatment adherence (r = -0.37, p < 0.01; r
= 0.31, p < 0.025).
Blood glucose meters may also have other data management capabilities, which
allow data to be downloaded to diabetes-specific computer software, where information
can be compiled to construct charts and graphs. Additional information such as food
consumed and exercise may be added to form a more complete picture of the patient’s
diabetes management. Technological advances in meters also may allow a wireless
connection to the user’s insulin pump, which permits diabetes information, such as
insulin boluses and blood glucose numbers, to be viewed in one place for ease of
treatment decisions. Downloading blood glucose monitor data is useful because families,
as well as a health care provider, can review a month or more of blood glucose numbers.
A more comprehensive appraisal of the data allows youth and parents to see patterns and
appropriately adjust treatment, if necessary.
Nutrition
Nutritional intake increases blood glucose levels and can be used to treat
hypoglycemic episodes; conversely, meals and snacks require treatment with insulin to
prevent hyperglycemia. Little dietary research on youth with T1D is available, so healthy
eating guidelines for all youth are encouraged (Silverstein et al., 2005). A low-glycemic
diet improves nutritional intake and reduces episodes of hyperglycemia due to the overall
reduction in glycemic content of food ingested (Rovner, Nansel, & Gellar, 2009). Total
carbohydrate content of meals and snacks is used to establish insulin doses before eating
(Mehta, Quinn, Volkening, & Laffel, 2009; Wolever et al., 1999). Youth who report
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higher levels of compliance to nutritional guidelines also report increased blood glucose
monitoring (Mehta et al., 2008).
Exercise
Exercise is an effective way to lower blood glucose levels via enhanced
absorption of cellular glucose into cells (Johnson, 1988; Silverstein et al., 2005). Despite
the positive effects of exercise on blood glucose, studies find no relation between adults’
physical fitness level and HbA1c (Campaigne, Gilliam, Spencer, Lampman & Schork,
1984; Raile et al., 1999). The American Diabetes Association (2011) recommends youth
adhere to guidelines set by the Centers for Disease Control (CDC) and American
Academy of Sports Medicine in 2009, and engage in moderate physical activity for a
minimum of 30 to 60 minutes daily. Youth also should monitor blood glucose levels
before, during, and after exercise, and ingest 15 grams of carbohydrates before activity in
order to keep blood glucose levels steady (Silverstein et al., 2005). Before starting a new
exercise regimen, consultation with a youth’s health care provider is recommended in the
event insulin doses require modifications to accommodate blood glucose changes
resulting from exercise.
Prevention and Intervention Behaviors
In this study, intervention and prevention behaviors are defined as youth
responses to and preparations for high and low blood glucose levels, respectively
(Iannotti et al., 2006). As mentioned above, recommendations exist that should be
followed in order to maintain euglycemia, and when hypo- or hyperglycemia occurs,
actions must be taken in order to return to euglycemia. Intervention behaviors may
include nutritional intake in reaction to hypoglycemia and insulin administration, water
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ingestion, and exercise in response to hyperglycemia. Prevention behaviors include
administration of insulin before meals and snacks, or carbohydrate intake prior to
physical activity. However, youth with T1D do not always follow guidelines, and several
studies have attempted to integrate the layers of a child’s ecosystem in order to promote
higher levels of disease care behaviors (Anderson, Brackett, Ho, & Laffel, 1999; Ellis et
al., 2005). No studies have examined the relation between parental monitoring and
prevention and intervention behaviors in youth. Establishment of this correlation will
add further detail to the existing connection between parental monitoring, disease care
behaviors, and metabolic control.
Blood Glucose Recommendations by Age Group
Blood glucose recommendations are separated into age groups due to different
developmental concerns. As the bioecological theory suggests, microsystems of youth at
these age groups are qualitatively different; for example, younger youth may not yet
attend school, and older youth may be employed or otherwise away from home for long
periods of time.
Youth under six years old may be unable to effectively convey symptoms of
hypoglycemia (Desrocher & Rovet, 2004), and nighttime hypoglycemia is also a greater
concern for this age group. Further, the total caloric intake and mealtime schedule of this
age group is less predictable, so insulin administration must be given carefully to avoid
extreme glycemic excursions. Glycemic excursions are characterized by variable blood
glucose readings, with the presence of more extreme hyper- and hypoglycemia (Garg et
al., 2006). Before meals, recommended blood glucose levels are between 100 and 180
mg/dl. At bedtime and during the night, preferred levels range between 110 and 200
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mg/dl, in order to avoid hypoglycemic episodes due to lack of caloric intake. The ADA
recommends an HbA1c of less than 8.5% for this age group (2011).
For youth aged six to twelve, many concerns of the younger group are less
significant because youth in this age group more effectively communicate the symptoms
of hypoglycemia. Even so, parents still need to assume primary responsibility for the
diabetes regimen (Johnson et al., 1982). Blood glucose levels before meals are
recommended between 90 and 180 mg/dl, and levels before bedtime and during sleep
between 100 and 180 mg/dl. An HbA1c of <8% is recommended (ADA, 2011).
For adolescents aged 13 to 19, there is more research concerning treatment
recommendations (Silverstein et al., 2005). Blood glucose levels before meals should be
between 90 and 130 mg/dl and levels ranging from 90 to 150 mg/dl are advised for
bedtime and throughout the night. Recommended HbA1c levels are slightly higher than
adults to avoid episodes of hypoglycemia, so the standard suggestion for this group is
7.5% or less (ADA, 2011).
Fear of hypoglycemia
Youth fear of hypoglycemia. T1D requires increased developmental
responsibility for adolescents, which can be associated with generalized anxiety, and
specifically, youth fear of hypoglycemia (Borus & Laffel, 2010). Youth may develop a
fear of hypoglycemia due to previously explained negative physical symptoms,
unconsciousness, and the possibility of death (Gonder-Frederick et al., 2006). Youth
with anxiety symptoms and T1D may have elevated blood glucose levels which can
increase anxiety because of the considerable disease care behaviors required, as well as
possible complications if HbA1c levels are too high (Anderson et al., 2002; Anderson,
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Miller, Auslander, & Santiago, 1981). Fear of hypoglycemia in youth is a disease
specific indicator of anxiety pertinent to the present investigation.
Hypoglycemia is the most common adverse event associated with insulin
administration in T1D (Wild et al., 2007). Reported incidence rates of severe
hypoglycemia (<70 mg/dL) that can result in seizures or unconsciousness range from .02
to 1.26 episodes per year in youth (Dammacco, Torelli, Frezza, Piccinno, & Tansella,
1998; Davis, Keating, Byrne, Russell, & Jones, 1998; Ludvigsson & Nordfeldt, 1998;
Mortensen & Hougaard, 1997). Youth fear of hypoglycemia also is related to more
frequent hypoglycemia and glycemic variability (Irvine, Cox, & Gonder-Frederick, 1992;
Polonsky, Davis, Jacobson, & Anderson, 1992; Shiu & Wong, 2002).
Youth may respond incorrectly to an episode of hypoglycemia, perhaps due to its
negative cognitive effects of dizziness, light-headedness, and diminished attention
(Johnson, Perwien, & Silverstein, 2000; Lobmann et al., 2000; Ryan et al., 1990).
Incorrect hypoglycemic responses include checking ketones or inaction. If youth are
unable to effectively treat hypoglycemia and blood glucose levels drop as a result, they
may experience seizures and unconsciousness. Severe episodes of hypoglycemia are
very frightening for youth with T1D and may generate or reinforce a youth and parent
fear of hypoglycemia. Youth may have difficulty detecting hypoglycemia; youth failed
to detect 41% of blood glucose readings below 55 mg/dL. Participants also incorrectly
believed blood glucose levels to be too high, when they were too low, 11% of the time
(Gonder-Frederick et al., 2008). Youth also may have difficulty differentiating between
anxiety and hypoglycemia (Polonsky et al., 1992).
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Several studies have explored the incidence of fear of hypoglycemia in youth. A
history of seizures or loss of consciousness due to severe hypoglycemia relates to higher
levels of hypoglycemic fear, greater worry about diabetes, and a greater negative impact
of diabetes on a youth’s life (Marrero, Guare, Vandagraff, & Fineberg, 1997). Girls have
higher worry scores than boys on the Hypoglycemic Fear Survey (Gonder-Frederick et
al., 2006). A correlation between youth fear of hypoglycemia and lower insulin
adherence (r =-0.39, p <.05) suggests youth fear of hypoglycemia may result in attempts
to stay hyperglycemic (Di Battista, Hart, Greco & Gloizer, 2009).
Parent fear of hypoglycemia. Anxiety literature has long demonstrated a
relationship between parent and youth anxiety in healthy populations (Cooper, Fearn,
Willets, Seabrook, & Parkinson, 2006; Lenane et al., 1990; McClure, Brennan, Hammen,
& Le Brocque, 2001; Turner, Beidel, & Costello, 1987), but research is lacking when
applied to a disease-specific measure of anxiety such as youth fear of hypoglycemia.
Elevated fear of hypoglycemia in parents is associated with poorer metabolic
control in their youth, more severe hypoglycemic events during the past year, and comorbid disease in youth (Haugstvedt, Wentzel-Larsen, Graue, Søvik, & Rokne, 2009;
Patton, Dolan, Henry, & Powers, 2007). Parents with a higher fear of hypoglycemia
monitored youth’s blood glucose numbers more frequently throughout the day
(Haugstvedt et al., 2009). Metabolic control in youth is modestly correlated with high
parent scores on the Hypoglycemic Fear Behavior Subscale (r = 0.41, p = 0.05), which
implies that parents of youth with higher average blood glucose levels frequently perform
behaviors aimed at preventing hypoglycemia (Patton, et al., 2007). Parental fear of
hypoglycemia may translate into maladaptive behavior if youth are not old enough to
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perform the majority of disease care behavior; for example, parents may keep youth’s
blood glucose levels higher to prevent severe hypoglycemic episodes.
Parental monitoring
Increased parental monitoring consistently relates to better diabetes disease care
behaviors and metabolic control (Miller-Johnson et al., 1994; Wysocki et al., 2009).
However, as youth grow older, parents become less involved and give more
responsibility to youth, which results in decreased adherence to the diabetes regimen,
including less frequent blood glucose monitoring, poorer diet, and higher HbA1c (Ellis,
Naar-King, Frey, Rowland, & Greger, 2003; Miller-Johnson et al., 1994). Parental
monitoring in the diabetes regimen is crucial to healthy navigation of diabetes in
adolescence.
T1D is a complex disease, and parental monitoring is considered a necessary
factor for successful management of T1D (Anderson, Bracket, Ho, & Laffel, 1999;
Anderson et al., 2009). The ADA (2011) recommends parents assume responsibility for
the majority of blood glucose monitoring until youth are at least eight years old. Current
recommendations emphasize shared diabetes responsibility between parent and youth
through adolescence (Silverstein et al., 2005). Parental attempts to stay involved in
diabetes care during the transition from youth to adolescence may lead to increased levels
of parent-youth conflict (Amato 2001; Amato & Keith 1991). Several longitudinal
studies show that parent-youth conflict may lead to poorer metabolic control (Laffel et
al., 2003; Williams, Laffel, & Hood, 2009). If parental monitoring and family conflict
are not separated, parental monitoring may be misattributed as deterioration of metabolic
control.
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In examination of the transition from youth to adolescence, transformation of a
youth’s ecology should be examined as well. Not only does the parent-youth relationship
change due to perceptions of increased maturity, but teachers and other figures in a
youth’s life may have qualitatively different expectations for them (Strawhacker, 2001).
A higher HbA1c also typically occurs during this transition, due to impaired insulin
action in puberty (Amiel et al., 1986). This may frustrate youth and lead to more
fluctuations in blood glucose levels as a result of increased anxiety (Silverstein et al.,
2005). The literature consistently supports the positive influence of parental monitoring
on overall adherence to a diabetes regimen, but parental monitoring has not been
specifically linked to youth correction of high or low blood glucose levels (Helgeson,
Reynolds, Siminerio, Escobar, & Becker, 2008). Validation of this relation will further
emphasize the positive influence of parental monitoring on youth disease care behaviors.
Statement of Problem
The purpose of the present study was to evaluate the relation among biological,
behavioral, and psychosocial factors, and metabolic control (HbA1c). Confirmation of a
relation between average blood glucose levels and HbA1c could confirm the latter as a
representative indicator of overall metabolic control in youth. Parental monitoring was
investigated as a mediator of this relation. If level of parental monitoring mediates the
relation between glycemic variability and metabolic control, intervention programs may
be constructed to improve metabolic control of youth by maintaining parental monitoring.
Blood glucose monitoring was examined to determine if more frequent blood glucose
monitoring correlates with better metabolic control. Confirmation of this hypothesis will
reinforce the literature and support current ADA recommendations of several blood
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glucose checks throughout the day (ADA, 2011). Two measures of glycemic variability,
ADRR and MAGE, were compared on the basis of correlation with HbA1c to determine
which is more highly correlated. Determination of the more accurate technique will
determine the best method by which to analyze blood glucose fluctuations. Youth and
parent fear of hypoglycemia were examined as a moderator of the relation between blood
glucose levels below, within, and above range, and HbA1c. Since previous episodes of
severe hypoglycemia are associated with youth and parent fear of hypoglycemia, an
attempt may be made to prevent hypoglycemic episodes by maintaining hyperglycemia,
which could result in elevated HbA1c. Finally, parental monitoring was assessed to
determine if it contributes to Prevention and Intervention behaviors performed in
response to out of range blood glucose levels. A better understanding of these relations
may aid clinicians in development of treatment programs for youth and their parents
aimed at improving metabolic control.
Few, if any, studies to date have used downloaded blood glucose readings from
routine clinical care as a measure of glycemic variability and assessed their association
with psychosocial factors, specifically fear of hypoglycemia and parental monitoring.
Further, the ADRR analysis of glycemic variability has not been used in youth
populations, and a significant relation to HbA1c will help establish its utility in pediatric
studies. Confirmation of the proposed relations in this study may help guide treatment
recommendations as well as intervention formulation for fluid, multi-layered youth
populations.
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Hypotheses
1.

Average blood glucose levels will significantly relate to metabolic control
(HbA1c).

2.

Higher frequency of blood glucose monitoring will be related to better
metabolic control.

3.

ADRR will be more highly related than MAGE with metabolic control.

4.

Parental monitoring will be positively related to more Intervention and
Prevention Behaviors in response to hyperglycemia and hypoglycemia.

Mediators/Moderators
1.

The relation between average blood glucose levels over the previous 30 days
and metabolic control will be mediated by parental monitoring, with increased
parental monitoring related to better metabolic control.

2.

Fear of hypoglycemia will moderate the relation between the percentage of
blood glucose levels below, within, and above range and metabolic control,
with increased youth and parent fear of hypoglycemia related to more out-ofrange blood glucose levels and poorer HbA1c levels.

Method
Participants
Participants were adolescents recruited between ages 11 and 14 along with a
parent or chief caregiver, who visited a healthcare practitioner at one of two metropolitan
pediatric endocrinology clinics. Data were collected from follow-up assessments of a
longitudinal randomized clinical trial (RCT) of parental monitoring in youth’s T1D care.
Inclusion criteria required a diagnosis of T1D for at least one year prior to enrollment, no
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other major chronic illness or injury, absence of mental disability, and fluency in reading
and writing English. This sample was comprised of 106 participants; 64 girls (61.0%), mean
age of 14 years (SD = 1.3), 30-day average blood glucose level of 216 mg/dl (SD = 53.7) and
HbA1c of 8.8 (SD = 1.5). The sample was self-identified as 69.5% Caucasian, 17.1% African
American, 6.7% Hispanic, and 6.7% Pacific Islander or Other. Participant characteristics are
displayed in Table 1.

Table 1.
Participant Characteristics (n=107)
n (%)
Male

41 (39%)

Female

64 (61%)

Ethnicity: Caucasian

73 (69%)

African American

18 (17%)

Hispanic

7 (7%)

Pacific Islander

1 (1%)

Other

6 (6%)

Insulin Regimen: CSII or

54 (53%)

pump
Intensive
Conventional

29 (28%)
19 (19%)

Procedure
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Sample youth and parents were participants in a RCT intended to prevent
deterioration in youth diabetes disease care. Written parental consent and youth assent
were obtained and youth and one parent were seen in conjunction with their regular
pediatric endocrinology appointment. Through study follow-up assessments, collection
of blood glucose data became available for analysis. During an evaluation, a trained
research assistant interviewed parent and youth separately and disseminated
questionnaires. Youth and families received $75 for participation. Data were drawn from
the most current session available for a youth that had accompanying blood glucose data.
At least three blood glucose values per day over a 30-day period were extracted from
youths’ blood glucose meters as a requirement for study inclusion; if blood glucose data
were not obtained at an appointment, the participant was excluded from participation in
these analyses.
Measures
Blood Glucose Levels
Blood glucose levels from the previous 30 days were obtained from participant’s
blood glucose meters’ memory. Both ADRR and MAGE provide optimal results from 30
days of data; however, a minimum of 14 days in the previous 30 with three blood glucose
checks is necessary for the glycemic variability calculations (Kovatchev et al., 2006;
Service et al., 1970). Only conventional blood glucose meters were included. Data were
obtained during assessments at youth’s endocrinology visits. Blood glucose meters were
downloaded onto a laptop computer through the use of brand-supplied specific software
and cables. If blood glucose meters were unable to be downloaded, numbers were
manually copied from meters by research assistants in the clinic and later entered into a
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computer database. Family generated blood glucose logs that were hand-written were not
included due to concerns about their reliability (Gonder-Frederick, Julian, Cox, Clarke, &
Carter, 1988). If families did not have downloadable or blood glucose meter data that
could be transcribed in the clinic, their assessment data could not be included in the
study.
Blood glucose levels were classified into three categories: readings below
recommended range (<70 mg/dl), readings within recommended range (70-200 mg/dl),
and readings above recommended range (>200 mg/dl). These ranges were calculated to
determine independently the correspondence of each glycemic variability measure with
ADA blood glucose range criteria and examine the sensitivity of each measure to ADA
blood glucose range criteria.
Blood Glucose Monitoring
The 24-hour Diabetes Interview (Holmes, et al., 2006 adapted from Johnson,
1986) is a disease care measure which focuses on highly specific behavior over a
relatively brief time period. Administration time is approximately 25 minutes, per
interview for parent and youth, separately. The seven disease care domains include: 1)
Frequency of Blood Glucose Monitoring, 2) Meal/Snack Frequency, 3) Percentage of
Daily Calories from Fats and 4) Carbohydrates, 5) Exercise Duration, 6) Exercise
Frequency, and 7) Insulin Regimen. This study only utilized the Frequency of Blood
Glucose Monitoring domain. Parent and youth are interviewed on two separate occasions
within a two week period. Participants are asked to recall the previous 24-hours in
temporal sequence from the time the youth wakes. The interviewer records all diabetes
relevant activities which include: Insulin injections, blood glucose monitoring, nutritional
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intake, and exercise. The interviewer asks the time, who performed a behavior, whether
an adult observed, and whether a parent or adult discussed the activity with the youth for
each disease care behavior. Blood glucose levels are obtained from a youth’s blood
glucose meter read by the parent or youth. Those who administer the 24-hour interview
submit to an intensive training process to ensure inter-rater reliability and familiarity with
the measure and scoring process. Acceptable parent-youth agreement, test-retest
reliability, internal consistency, and predictive validity have been found (Freund,
Johnson, Silverstein, & Thomas, 1991; Johnson, 1986).
ADRR
The ADRR calculation requires at least 14 days out of 30 days where three blood
glucose readings were taken per day (Kovatchev et al., 2006). Blood glucose values are
normalized using a logarithmic data transformation that matches the clinical and
numerical center of the blood glucose scale, thus making the transformed data symmetric;
without this data transformation, many parametric statistical assumptions are violated
unknowingly. After the data are transformed, blood glucose readings are converted into
risk values, using all of the readings below the mean and all of the readings above the
mean as overall indicators of risk for hypo- and hyperglycemia (Kovatchev et al., 2006).
ADRR values are distributed into three categories based on established categories derived
from data with adult samples: levels lower than 20 indicative of low risk, values 20 to 40
demonstrative of moderate risk, and values greater than 40 characteristic of high risk
(Kovatchev et al., 2006).
MAGE
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To compute MAGE, the difference from the previous blood glucose value is
calculated for each individual blood glucose value. Each difference score is compared
against the average of all blood glucose values in that day and only differences exceeding
one standard deviation from the average are included. The arithmetic mean of the
remaining differences is calculated, resulting in the MAGE value. MAGE values have a
possible range of 20 to greater than 125. MAGE values greater than 125 indicate the
participant is an “unstable diabetic” (Service et al., 1970).
Parental monitoring
The Parental Monitoring of Diabetes Care Scale (PMDS) is a 19-item
questionnaire that measures parental monitoring and involvement in their youth’s daily
diabetes management and care (Ellis et al., 2008). It has two versions, one parent-report
and one child-report; for this study, parent and child report scores were averaged and the
resultant mean score was used in statistical analyses. Eighteen items are rated on a fivepoint Likert scale (1 = more than once a day to 5 = less than once a week), while the last
item is an open-ended item. Subscales include 1) Supervision of the Availability of
Medical Supplies/Devices, 2) Monitoring of Blood Glucose Checking, 3) Oversight of
Diet, 4) Monitoring of Nonadherence, and 5) Direct Oversight of Diabetes Management
Behaviors. A total score is obtained by summing all items after reverse scoring; possible
scores range from 18-90. This study examined the summation of all subscales for a total
parental monitoring score. Analyses show the mean total score to be 72.87 +/- 9.83, with
acceptable internal consistency (.81) and test-retest reliability (.80) (Ellis et al., 2008).
Fear of hypoglycemia
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The original Hypoglycemic Fear Survey (HFS; Irvine, Cox, & Gonder-Frederick,
1987) was used to measure fear experienced with respect to hypoglycemia, with both
parent and youth versions. Youth and parent report were averaged in this study to
describe the family’s overall fear of their child becoming hypoglycemic. The HFS is a
27-item self-report scale later revised to include only 23 items rated on a five-point Likert
scale (0 = never to 4 = always) (1994). Subscales include Worry and Behavior, but only
the Worry subscale from the youth version was used. A total score is attained by
summing all responses, with possible scores ranging from zero to 52. Analyses show the
mean total score to be 38 +/- 12, with superior internal consistency (.96) and good testretest reliability (.64-.76) (Irvine, Cox, & Gonder-Frederick, 1994).
Diabetes Care Behavior
The Diabetes Behavior Rating Scale (DBRS) is a self-report measure of youth
disease care which uses report by parent and youth separately (Iannotti et al., 2006).
Subscales include Daily Prevention Behaviors (0 = never to 4 = always), Modification of
Diabetes Care Plan (0 = never to 5 = five times), Intervention Behaviors (0 = none to 5 =
five times), and Other Diabetes Care Practices (0 = never to 5 = five times). This study
only examined the Intervention and Prevention Behavior subscale responses averaged
from youth and parent questionnaires. Only these subscales were included because they
reflect self-care behaviors performed in reaction to or prevention of blood glucose values
out of range. Intervention and Prevention Behavior subscale responses provide
information about youth responses to and preparations for high and low blood sugars.
Analyses show the mean total score to be .75 +/- .10, with satisfactory internal
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consistency (.84), test-retest reliability (.71), and parent/youth agreement (.48) (Iannotti
et al., 2006).
Metabolic Control
Metabolic control was determined by HbA1c level at the time of a youth’s
medical appointment. The HbA1c level was measured with a Bayer DCA 2000
Analyzer, which delivers in office results in five minutes at the time of a youth’s
endocrinology appointment. DCA 2000 Analyzer HbA1c values are strongly correlated
with the Diabetes Control and Complications Trial/Epidemiology of Diabetes
Interventions and Complications central laboratory values (r = .940, p < .001), which
serve as a reference standard against which other assays are compared (Tamborlane et al.,
2005). HbA1c levels were obtained from medical records after meeting with participants
and obtaining consent at initial assessment.
Socioeconomic Status
Socioeconomic status (SES) was determined with the Hollingshead Index of
Socio-Economic Status (Hollingshead, 1975). Parents of youth participants completed
this worksheet with information regarding marital status, employment status, and
education level for both parents (except in single parent households). Scores range from
8-66 and are grouped into five social classes: Class V (8-17), Class IV (18-28), Class III
(29-47), Class II (48-59), and Class I (60-66). Lower classes (higher scores) indicate
higher SES. Raw scores were used in these analyses.
Data Analysis Plan
Initial data cleansing identified univariate and multivariate outliers, which were
transformed, Winsorized, or removed, based on the severity of deviation from the data
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set. Residual scatterplots were examined for normality, linearity, and homoscedasticity,
and data were checked for multicollinearity, and singularity. Each participant’s blood
glucose data were examined to verify three or more blood glucose checks per day, at least 14
days out of 30, were performed. If these criteria were not met, the participant was excluded
from analyses. Blood glucose values were then formatted appropriately for each formula and
calculations were performed to obtain ADRR and MAGE values for each participant.

A correlation coefficient matrix was completed to determine correlations between
HbA1c and all variables of interest, including average blood glucose levels per
participant, frequency of blood glucose monitoring, MAGE, and ADRR values.
Pearson’s r was also calculated to determine the relation of parental monitoring to
Intervention and Prevention behaviors performed by youth, as measured by the DBRS.
Hierarchical multiple regressions were performed with average blood glucose levels as
the independent variable, HbA1c as the dependent variable, and PMDS total parental
monitoring score entered as a mediator. Blood glucose levels were then classified into
three categories: readings below recommended range (<70 mg/dl), readings within
recommended range (70-200 mg/dl), and readings above recommended range (>200
mg/dl). Hierarchical regression analyses were performed for youth and parent fear of
hypoglycemia on the HFS and the percentage of blood glucose readings below, within,
and above range predicting HbA1c.
Results
A logarithmic transformation was performed on the variable “Frequency of Blood
Glucose Monitoring” due to high skewness and kurtosis values. Homogeneity of
variance of the data was confirmed by a nonsignificant Levene’s Test of Equality of
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Variances for each variable. Finally, graphs of all variables confirmed normal
distribution of the data.
This study sample was comprised of mostly middle-class participants, with a
mean Hollingshead Index of 46.6 (SD = 13.2). The sample generally was in moderate
metabolic control, with a mean HbA1c level of 8.8% (SD = 1.5). The average sample
blood glucose value was 216 mg/dl with a range of 124-400 mg/dl (SD = 53.7). On
average, blood glucose levels were checked 3.9/day (SD = 1.4). Both ADRR and MAGE
values were found to be high in this sample, with 67.6% maintaining “high risk” ADRR
values and 85.9% categorized as “unstable diabetic range” according to their MAGE
values. No participants had “low risk” ADRR values and only 14.1% of participants
were in the “stable diabetic range” per MAGE values. Parental monitoring scores were
high for this sample, with a mean score of 75.8 (SD = 6.8) on the PMDS. Prevention and
Intervention scores were in the moderate range, with means and standard deviations of
46.2 (SD = 9.2) and 25.4 (SD = 4.9), respectively. Scores on the Hypoglycemic Fear
Survey were low, indicating a minimal youth and parent fear of hypoglycemia among
these youth, with a mean score of 14.9 (SD = 7.6). Means and standard deviations of all
psychosocial and disease care variables examined in this study are reported in Table 2.
The correlation matrix of all variables is displayed in Table 3.
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Table 2.
Sample Disease Care and Psychosocial Characteristics (n=107)
M (SD)

Range

SES

46.6 (13.2)

11.0-66.0

Age

14.4 (1.3)

12.5-16.9

HbA1c %

8.8 (1.5)

6.6-14.0

Average BG Level

216 (53.7)

124.0-400.0

% Below (< 70 mg/dl)

9.2 (7.6)

0.0-32.5

% Within (70 – 200 mg/dl)

41.2 (14.2)

6.6-83.3

% Above (> 200 mg/dl)

49.0 (17.9)

7.7-93.4

ADRRa

47.4 (12.5)

24.6-75.9

MAGEb

163.6 (37.9)

102.5-277.5

BG Freq

3.9 (1.4)

1.3-9.5

Fear of Hypoglycemia (HFS)c

14.9 (7.6)

2.0-46.0

Adherence (DBRS): Prevention

46.2 (9.2)

27.5-67.5

Intervention 25.4 (4.9)

12.5-35.0

Parental Monitoring (PMDS)d

75.8 (6.8)

a

57.0-89.0

ADRR: lower values indicate lower glycemic variability. bMAGE: lower values indicate lower glycemic
variability. cHypoglycemic Fear Scale (HFS): higher values indicate greater youth and parent fear of
hypoglycemia. dParental Monitoring of Diabetes Scale (PMDS): higher scores indicate greater parental
monitoring.
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Table 3.
Correlations between Demographic, Disease Care, Psychosocial Variables from Sample
1.
1. Age

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

-

2. HbA1c

.061

-

3. Avg BG Level

.083

.660***

-

4. % Below

.018

-.354***

-.615***

-

5. % Within

-.041

-.529***

-.838***

.255**

-

6. % Above

.004

.612***

.895***

-.637***

-.833***

-

7. ADRRa

.111

.422***

.605***

.067

-.703***

.419***

-

8. MAGEb

.179

.405***

.564***

-.025

-.578***

.291*

.834***

-

9. BG Freq

.109

-.08

.015

-.045

.021

-.007

-.089

.043

-

10. HFSc

.015

.272**

.157

.021

-.176

.165

.125

-.003

.016

-

11. Prev

-.428***

-.279**

-.304**

.135

.154

-.152

-.153

-.387***

-.010

-.239*

-

-.164

-.158

-.208*

.147

.153

-.193*

-.072

-.117

-.249*

.000

.259**

-

-.345***

-.259**

-.243*

.071

.153

-.121

-.241*

-.444***

.143

-.104

.668***

.051

-

.098

-.343***

-.424***

.154

.326***

-.319**

-.221

-.134

-.084

-.228*

.148

.387***

-.031

12. Int
13. PMDSd
14. SES

Note. *p<.05. **p<.01. ***p<.001. ADRRa: lower values indicate lower glycemic variability. MAGE b: lower values indicate lower glycemic variability. HFSc:
higher values indicate more fear of hypoglycemia. PMDSd: higher scores indicate more parental monitoring. Socio-economic Status (SES): Higher scores
indicate higher SES.
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Relation between Average Blood Glucose Levels and HbA1c
Pearson’s r was calculated to determine the relation between HbA1c and average
blood glucose levels. There was a significant positive correlation between metabolic
control and average blood glucose levels (r = .66, p < .001).
Relation between Frequency of Blood Glucose Monitoring and HbA1c
Pearson’s r was calculated to determine the relation between HbA1c and
frequency of blood glucose monitoring. The transformed frequency of blood glucose
monitoring variable was used in this analysis. Frequency of blood glucose monitoring
was not found to be correlated with metabolic control as hypothesized, (r = -.08, p =
.419).
Relation among HbA1c, ADRR, and MAGE
Pearson’s r was calculated to determine the relation between HbA1c and MAGE
and ADRR. ADRR and MAGE were equivalently correlated with HbA1c, with
correlations of (r = .42, p < .001) and (r = .41, p < .001), respectively.
Relation among Parental Monitoring, Intervention Behaviors, and Prevention
Behaviors
Pearson’s r was calculated to determine the relation between parental monitoring
and intervention and prevention behaviors as performed by youth. Prevention behaviors
were strongly correlated with parental monitoring, (r = .67, p < .001). Intervention
behaviors were not related to parental monitoring as hypothesized, (r = .05, p = .610).
Effect of Parental Monitoring on Relation between Average Blood Glucose Levels
and HbA1c
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A Baron & Kenny mediation analysis (1986) was performed with multiple
regressions to determine whether parental monitoring mediated the relation between
average blood glucose levels and HbA1c. Multiple regression indicated a relation
between average blood glucose levels and HbA1c (B =.02, β = .66, p =.000). Next, a
relation between average blood glucose levels and parental monitoring (B =-.03, β = -.24,
p =.013) was established. However, the effect of parental monitoring on HbA1c was not
significant (B = -.11, β = -.02, p =.173). As a final step in the mediation analysis, a
regression was conducted with both parental monitoring and average blood glucose levels
as predictors of HbA1c. As Figure 1 illustrates, the relation between average blood
glucose levels and HbA1c was not mediated by parental monitoring, because the relation
between average blood glucose values and HbA1c remained significant (B =.01, β = .64,
p =.001).

β = -.24
p = .013*
Average Blood
Glucose Values

Parental
monitoring

β = .66
p < .001***

β = -.02
p = .173
Metabolic
Control (HbA1c)

β = .64
p < .001***
Figure 1. Standardized regression coefficients for the relation between average blood glucose
values and metabolic control as mediated by parental monitoring. The standardized
regression coefficient between average blood glucose values and metabolic control
controlling for parental monitoring is in brackets.
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Effect of Fear of Hypoglycemia on Percentage of Blood Glucose Levels Below,
Within, and Above Range, and HbA1c
A Baron & Kenny moderation analysis (1986) was performed to determine
whether fear of hypoglycemia moderated the relation between percentage of blood
glucose levels below, within, and above range, and HbA1c. Using a hierarchical multiple
regression equation in PASW, the percentage of blood glucose levels below, within, or
above were entered in step 1. In step 2, the percentage of blood glucose levels below,
within, or above were entered and HFS scores. In step 3, percentage of blood glucose
levels below, within, or above range were entered; HFS scores; and the interaction term
of the two variables. Results are presented below in Table 4.
Table 4.
Moderation Analyses Examining Effects of Fear of Hypoglycemia on the Relations
between Percentage of Blood Glucose Levels Below, Within, and Above Range and
HbA1c
____% Below____
B
t
P

Step 1
%
Step 2
%
HFS
Step 3
%
HFS
% x HFS

____% Within____
B
t
p

___% Above____
B
t
P

-.07

-3.80

.000

-.05

-6.30

.000

.05

7.87

.000

-.08
.04

-3.89
1.35

.000
.180

-.05
-.01

-6.20
-.67

.000
.503

.05
.03

7.88
1.27

.000
.206

-.09
.04
-.00

-3.55
1.37
.31

.001
.173
.759

-.05
-.01
-.00

-5.97
-.68
.72

.000
.498
.474

.05
.02
.00

7.84
1.24
-.31

.000
.217
.761

Percentage of blood glucose levels below range were inversely related to HbA1c
( = -.07, t = -3.80, p = .000). Fear of hypoglycemia was not significantly related to
HbA1c ( = .04, t = 1.35, p = .180). Fear of hypoglycemia did not significantly moderate
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the association between percentage of blood glucose levels below range and HbA1c (
=.00, t = .31, p = .759) (See Figure 2).

10

HbA1c

9

+1 SD on
CHFS

8

Mean on
CHFS
-1 SD on
CHFS

7

6
Percentage of Blood Glucose Values Below
Range
Figure 2. Sample slopes of blood glucose values below range predicting HbA1c for 1 SD
below the mean of fear of hypoglycemia, the mean of fear of hypoglycemia, and 1 SD
above the mean of fear of hypoglycemia.
Percentage of blood glucose levels within range were inversely related to HbA1c
( = -.05, t = -6.30, p = .000). Fear of hypoglycemia was not significantly related to
HbA1c ( = -.01, t = -.67, p = .50). Fear of hypoglycemia did not significantly moderate
the association between percentage of blood glucose levels below range and HbA1c ( =
.00, t = .72, p = .47) (See Figure 3).
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10

HbA1c

9
+1 SD on
CHFS
Mean of
CHFS
-1 SD on
CHFS

8

7

6

Percentage of Blood Glucose Levels Within
Range

Figure 3. Sample slopes of blood glucose values within range predicting HbA1c for 1 SD
below the mean of fear of hypoglycemia, the mean of youth and parent fear of
hypoglycemia, and 1 SD above the mean of fear of hypoglycemia.

Percentage of blood glucose levels above range were positively related to HbA1c
( = .05, t = 7.87, p = .000). Fear of hypoglycemia was not significantly related to
HbA1c ( = .03, t = 1.27, p = .206). Fear of hypoglycemia did not significantly moderate
the association between percentage of blood glucose levels above range and HbA1c ( =
.00, t = -.31, p = .761) (See Figure 4).
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10

HbA1c

9
+1 SD on
CHFS
Mean of
CHFS
-1 SD on
CHFS

8

7

6
Percentage of Blood Glucose Levels Above
Range

Figure 4. Sample slopes of blood glucose values above range predicting HbA1c for 1 SD
below the mean of fear of hypoglycemia, the mean of fear of hypoglycemia, and 1 SD
above the mean of fear of hypoglycemia.

Unanticipated significant correlations were found among variables; only
significant findings related to SES, as well as ADRR high risk values will be reported and
discussed. SES was significantly correlated with HbA1c (r = -.34, p = .001), average
blood glucose level (r = -.42, p = .000), percentage of blood glucose values within range
(r = .33, p = .001), percentage of blood glucose values above range (r = -.32, p = .002),
and intervention behaviors (r = .39, p = .000). The ADRR high risk values were
significantly correlated with HbA1c (r = .55, p = .000), average blood glucose level (r =
.90, p = .000), percentage of blood glucose values below range (r = -.39, p = .001), within
range (r = -.79, p = .000), percentage of blood glucose values above range (r = .69, p =
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.000), prevention behaviors (r = -.24, p = .042), and parental monitoring (r = -.27, p =
.023).
Comparison of ADRR and MAGE to Percentage of Blood Glucose Levels Below,
Within, and Above Range
Comparison of ADRR and MAGE to blood glucose levels below, within, and
above recommended range was made to determine the correspondence of each glycemic
variability measure with ADA blood glucose range criteria and examine the sensitivity of
each measure to ADA blood glucose range criteria. ADRR was significantly related to
the percentage of blood glucose levels within range (r = -.70, p = .000) and blood glucose
levels above range (r = .42, p = .000). MAGE was significantly related to the percentage
of blood glucose levels within range (r = -.58, p = .000) and blood glucose levels above
range (r = .29, p = .014). Neither glycemic variability measure was related to percentage
of blood glucose levels below range.
Post-hoc Analyses
Post-hoc exploratory analyses with HbA1c, SES, and measures of metabolic
control were conducted to explore whether once controlling for SES, if ADRR or MAGE
added any information to HbA1c above any other metabolic control measures. A series
of hierarchical multiple regressions were performed. Average blood glucose value was
consistently the strongest predictor of HbA1c, followed by percentage of blood glucose
values below range, blood glucose values above range, and blood glucose values within
range. Results are shown below in Tables 5 through 8.
In a hierarchical multiple regression using SES, average blood glucose level,
percentage of blood glucose levels below range, percentage of blood glucose levels
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within range, and percentage of blood glucose levels above range as predictors of HbA1c,
all were significant except for SES. Average blood glucose levels were positively related
to HbA1c ( = .02, t = 3.63, p = .000), as were percentage of blood glucose levels below
range ( = .08, t = 2.61, p = .011), within range ( = .06, t = 2.36, p = .021), and above
range ( = .05, t = 2.42, p = .018). Results are shown below in Table 5.
Table 5.
Hierarchical Multiple Regression Examining Relation of HbA1c to Socioeconomic
Status, Average Blood Glucose Level, Percent Below, Within, and Above Range
_

SES
Average BG
% Below
% Within
% Above

B
> -.01
.02
.08
.06
.05

HbA1c_ _ _
t
-.65
3.63
2.61
2.36
2.42

P
.517
.000
.011
.021
.018

In a hierarchical multiple regression using SES, average blood glucose level, and
ADRR as predictors of HbA1c, only average blood glucose level was a significant
predictor of HbA1c ( = .01, t = 2.82, p = .007). Results are shown below in Table 6.
Table 6.
Hierarchical Multiple Regression Examining Relation of HbA1c to Socioeconomic
Status, Average Blood Glucose Level, and ADRR
_

SES
Average BG
ADRR

B
-.01
.01
.02

HbA1c_ _ _
t
-1.07
2.82
1.22

47

P
.29
.007
.227

In a hierarchical multiple regression using SES, average blood glucose level, and
MAGE as predictors of HbA1c, only average blood glucose level was a significant
predictor of HbA1c ( = .01, t = 3.19, p = .002). Results are shown below in Table 7.
Table 7.
Hierarchical Multiple Regression Examining Relation of HbA1c to Socioeconomic
Status, Average Blood Glucose Level, and MAGE
_

SES
Average BG
MAGE

B
-.01
.01
.00

HbA1c_ _ _
t
-1.15
3.19
1.14

P
.254
.002
.259

In a hierarchical multiple regression using SES and average blood glucose level as
predictors of HbA1c, only average blood glucose level was a significant predictor of
HbA1c ( = .02, t = 6.93, p = .000). Results are shown below in Table 8.
Table 8.
Hierarchical Multiple Regression Examining Relation of HbA1c to Socioeconomic Status
and Average Blood Glucose Level
_

SES
Average BG

B
-.01
.02

HbA1c_ _ _
t
-.955
6.93

P
.342
.000

The utility of separate high and low risk values in the ADRR calculation was also
explored. A Baron & Kenny mediation analysis (1986) was performed with multiple
regressions to determine whether parental monitoring mediated the relation between
ADRR high risk values and HbA1c. Multiple regression indicated a relation between
ADRR high risk values and HbA1c (B =.05, β = .549, p =.000). Next, a relation between
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ADRR high risk values and parental monitoring (B =-.54, β = -.27, p =.023) was
established. As a third step, a relation between parental monitoring and HbA1c (B =-.06,
β = -.26, p =.008) was established. As a final step in the mediation analysis, a regression
was conducted with both parental monitoring and average blood glucose levels as
predictors of HbA1c. The relation between ADRR high risk values and HbA1c was not
mediated by parental monitoring, because the relation between average blood glucose
values and HbA1c remained significant (B =.05, β = .52, p =.000), and the relation
between parental monitoring and HbA1c became nonsignificant (B = -.02, β = -.11, p
=.302).
Discussion

The current study explored pediatric blood glucose levels and compared different
measures of glycemic variability to a traditional measure of metabolic control (HbA1c).
Also, the current study sought to confirm existing research establishing frequency of
blood glucose monitoring as a predictor of better metabolic control. The relation of
parental monitoring with intervention and prevention behaviors was examined. Finally,
parental monitoring and fear of hypoglycemia were explored as potential mediators and
moderators, respectively, of the relation between glycemic variability and metabolic
control.
Average blood glucose levels were strongly related to HbA1c, confirming HbA1c
as an appropriate composite indicator of average blood glucose levels over the previous
30-day period. Current findings replicate, in a pediatric sample, relations found between
average blood glucose levels and HbA1c in adult populations with T1D (Hempe et al.,
2002). As most blood glucose meters may be downloaded, parents and youth may view
individual blood glucose levels over time, as well as a youth’s average blood glucose
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value, and gain an approximation of his or her average level of metabolic control. This
information will allow families to make adjustments in between their 3-month
endocrinology appointments. Additionally, blood glucose monitors allow families or
youth to track specific disease care behaviors (e.g., checking blood glucose levels before
sports practice) and to detect declines or fine-tune their insulin regimen.
Increased frequency of blood glucose monitoring is strongly related to better
metabolic control in the literature (Anderson et al., 1997; Bott et al., 1994; Vanelli,
Cerutti, Chiarelli, Lorini, & Meschi, 2005). However, the current study did not find a
relation between frequency of blood glucose monitoring and metabolic control. In this
sample, youth who checked blood glucose levels more frequently did not have lower
HbA1c levels compared with youth who checked blood glucose levels less frequently.
Several factors may contribute to the present lack of a relation; first, the sample was
limited to participants who remembered to bring their blood glucose meter to their
appointment, possibly excluding youth in poorer metabolic control who forgot or
purposefully did not bring their meter. Unintentionally forgetting to bring a meter is a
statistical shortcoming, while purposefully not bringing a meter is a diabetes care issue.
Finally, if youth with multiple blood glucose meters neglected to bring one of them, (e.g.,
they left their school meter at the nurse’s office), their data were incomplete, falsely
reflecting a lower frequency of blood glucose monitoring.
Thus far in the literature, neither ADRR nor MAGE have been used to examine
glycemic variability in pediatric populations with T1D. Both were related to HbA1c,
with ADRR and MAGE accounting for a small amount of the variance in HbA1c. These
findings establish each technique as an appropriate measure of glycemic variability in
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youth with T1D; however, average blood glucose level (automatically calculated by most
blood glucose meters) accounted for more than twice the amount of variance in HbA1c
than ADRR or MAGE.
While each glycemic variability method provides information about blood
glucose excursions, application is limited to youth who perform at least three or more
checks per day. ADRR requires at least 15 days out of a 30-day range that individuals
check blood glucose levels at least three times each day. Thus, data from youth who
neglect to check their blood glucose three or more times per day are not eligible for
analysis by this method. Additionally, ADRR and MAGE are both time-consuming to
compute without specialized software. Finally, ADRR and MAGE values in this sample
were very high, in with 79 to 91% in the ‘high risk’ categories, indicating greater
glycemic variability among youth in comparison with adult populations on which these
measures were developed. Sample average ADRR and MAGE values in adult
populations range from 25.5 (SD=7.95; Bruttomesso et al., 2007) to 33 (Kim et al.,
2011), and 65.6 (SD=34.9; Fabricatore, Ebbeling, Wadden & Ludwig, 2011) to 69.0
(SD=18.1; Marfella et al., 2009), respectively.
The risk categories established by ADRR and MAGE may not be the most
appropriate ranges for pediatric glycemic variability. Adolescents’ blood glucose levels
oscillate due to fluctuations in hormone production (Amiel et al., 1986). However, a
recalibration of a glycemic variability measure specifically for youth may provide useful
descriptive information within this group who experience a high level of glycemic
variability. If glycemic variability is to serve as a complementary measure of youths’
metabolic control, it must accurately reflect swings in blood glucose values. Neither
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glycemic variability measure was significantly associated with percentage of blood
glucose levels below range, indicating that neither measure is sensitive to hypoglycemic
fluctuations in blood glucose levels. Measures of glycemic variability should also
provide information above and beyond HbA1c, which did not occur in the current
sample.
Existing blood glucose variability measures such as ADRR and MAGE add little,
if any, descriptive information to youths’ metabolic control. If families seek additional
information about youths’ blood glucose levels and how they relate to youths’ metabolic
control, a more useful measure may be the percentage of blood glucose levels below,
within, and above the ADA recommended range of blood glucose values. Families may
calculate this comparison independently at home with a calculator, and it provides similar
information as more complex calculations such as ADRR or MAGE. Home calculation
of the percentage of blood glucose values below, within, and above ADA recommended
ranges may not be a realistic recommendation for daily diabetes management, but
families could obtain this information if they desired. Blood glucose levels within and
above range were more strongly correlated with HbA1c than ADRR or MAGE, and
easier to interpret (see Table 3). Many blood glucose meters, when downloaded,
automatically calculate the percentage of blood glucose levels below, within, and above
individually programmed ranges of blood glucose values, as well as the youth’s average
blood glucose level.
Parental monitoring was strongly correlated with prevention behaviors,
accounting for a large proportion of the variance in prevention behaviors performed by
families. The prevention behaviors subscale includes options such as “having supplies
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available,” which parents are more apt to do than youth. Parental monitoring was not
correlated with intervention behaviors; youth may be more intrinsically motivated to
address hypo- or hyperglycemia, as they don’t necessarily require parental prompting to
address high or low blood glucose levels. Conversely, youth may not perform
intervention behaviors as frequently as they perform prevention behaviors. Intervention
behaviors require decisions to be made which are not set in the diabetes regimen, may be
unexpected, and may occur at a time when the youth is away from his or her parents.
Thus, it may be more difficult for youth to perform these novel intervention behaviors
compared with more “automatic” prevention behaviors. Parents could work with youth
and problem-solve different situations to prepare them to act in these circumstances. For
example, parent and youth could explore solutions to treating hyperglycemia during
sporting events or planning for hypoglycemia by always carrying a fast-acting
carbohydrate.
Parental monitoring did not mediate the relation between average blood glucose
levels and HbA1c. This is most likely due to the strong mathematical relation between
average blood glucose levels and HbA1c, such that HbA1c levels may be expressed as
average blood glucose level for most patients with T1D (Lenters-Westra & Slingerland,
2008; Nathan et al, 2008; Sultanpur, Deepa, & Kumar, 2010). Further, perhaps it is not
surprising that the association between average blood glucose levels and HbA1c, two
biologic indicators, exceeds that of a relation with a psychosocial variable.
Fear of hypoglycemia did not moderate the relation between the percentage of
blood glucose levels below, within, and above range and HbA1c. The percentage of
blood glucose levels below, within, and above range accounted for more of the variance
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in HbA1c compared to fear of hypoglycemia. Overall, youths’ and parents’ fear of
hypoglycemia demonstrated a weak relation with the percentage of blood glucose levels
below range but no significant relations to levels within and above range. While results
were congruent with expected hypotheses of a relation between fear of hypoglycemia and
BG ranges, the association was weak, which contradicted expectation that youth who
feared low BG levels would maintain hyperglycemia.
Percentage of blood glucose values above range had the strongest relation to
HbA1c, followed by percentage of values within range, and was least related to
percentage of values below range. Results suggest that HbA1c may be most heavily
influenced by hyperglycemia, followed by euglycemia and hypoglycemia, which is
consistent with previous literature regarding HbA1c composition (Goldstein et al., 1993;
Rohlfing et al., 2002; Tahara, 1993).
As prevention behaviors increased in the sample, MAGE values decreased, which
suggests that lower glycemic variability is related to preventive disease care behaviors.
This indicates that youth who reliably perform the recommended number of blood
glucose checks and administer insulin on schedule as prescribed by their physician have
lower HbA1c values.
The literature has consistently shown a relation between SES and HbA1c in those
with T1D (Carter et al., 2008; Secrest et al., 2011; Tahirovic & Toromanovic, 2010).

Higher SES allows families to afford healthier foods and live in lower-stress
environments, both of which play a part in better metabolic control and may contribute to
the relation between SES and HbA1c. In turn, youth from lower SES families have
higher HbA1c which places them at greater long-term risk for complications from
diabetes (DCCT, 1994). There is a wealth of literature describing the strategies health
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professionals use with lower SES families. These include culturally sensitive assessment
tools by clinicians, engagement of community resources, support of public policy
allowing access to affordable healthcare, and access to affordable, high-quality child care
and support services (American Psychological Association [APA], 1998; APA, 1992;
Kawachi & Kennedy, 1997). Resources for free test strips for blood glucose meters,
healthier food at a lower cost, or support groups for youth with T1D to lower stress
among youth and families may also be included. Approaches such as these assist
families in finding solutions for barriers that may prevent youth from performing selfcare behaviors completely or consistently.
Parental monitoring did not mediate the relation between ADRR high risk values
and HbA1c. This finding may be due to the strong mathematical relation between ADRR
high risk values and HbA1c. Additionally, the association between ADRR high risk
values and HbA1c, two biologic indicators, exceeds any relation with a psychosocial
variable. The failure of ADRR high risk values to provide information beyond glycemic
control reinforces the conclusion that the percentage of blood glucose levels below,
within, and above range, are most useful to families, as they provide information beyond
HbA1c which is relatively easy to obtain and interpret.
Limitations
Limitations in this study relate primarily to the availability of participants’ blood
glucose data. Both of the glycemic variability indices under consideration, ADRR and
MAGE, have criteria that exclude youth who do not check their blood glucose regularly,
at least three times a day. Also, these formulas were developed using continuous blood
glucose monitoring (CGM), which has advantages over conventional blood glucose
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monitoring, such as a blood glucose reading every one to five minutes (Neithercott,
2011). All youth in the current sample used conventional blood glucose meters. Thus
data were lost if they failed to bring one of their meters to their appointment to be
downloaded and their data was unusable if they failed to complete sufficient blood
glucose checks. In addition to missing blood glucose data from meters, research
assistants occasionally forgot or were unable to download participant blood glucose
meters. Finally, as the download of blood glucose data was added after the start of the
RCT study, blood glucose data were incomplete for early participants. All of these
factors resulted in a reduced sample size and lower statistical power (Kazdin, 2003).
Future Directions
The current study demonstrated the use of blood glucose data downloaded from
pediatric participants’ blood glucose meters in a research capacity. In the future, blood
glucose data may be used to replace some parts of parent and youth questionnaires. For
example, the question of blood glucose monitoring frequency could be replaced with the
easy download of a blood glucose meter. This may be more accurate than a self-report
measure and take the same amount of time as filling out a form. As described previously,
ADRR and MAGE values in the current adolescent sample were high, with 79% of the
sample falling in the “high risk” category for ADRR values and 91% of the sample
falling in the “unstable diabetic range” for MAGE values. This renders relations to other
variables difficult to interpret.
A glycemic variability measure normed on adolescent samples and tailored for
youth could be explored in further studies, as results from the current study suggest
limited clinical utility of the existing measures. Percentage of blood glucose levels
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below, within, and above the recommended range proved to be simpler to calculate and to
more accurately portray blood glucose patterns than a composite index from either
glycemic variability measure. Blood glucose percentages also are more readily
interpreted by professionals and families. While ADRR and MAGE indicated that 80%
or more of the population was high risk, almost half, 41%, of all BG values in the sample
were within the ADA recommended range. Nevertheless, approximately 60% of BG
values were out-of-range which indicates that this issue is significant in pediatric groups.
Families should continue to be provided an HbA1c level every three months, and if they
are interested in fine-tuning their child’s diabetes regimen, percentage of blood glucose
values below, within, and above may be provided to guide self-care behaviors.
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